Il numero di infezioni con il coronavirus è di nuovo in aumento. La SSMI segue con la massima attenzione gli sviluppi nazionali e internazionali e prende sul serio la situazione sulla base dell'esperienza maturata precedente.
COVID-19: Documentation de la capacité de traitement dans le système d'information et d'intervention (SII) du Service sanitaire coordonné (SSC), documentation des cas dans les données minimales de la SSMI (MDSi) et des unités de soins intermédiaires (MDSimc) et indemnisation des cas de traitement
La propagation du virus corona a bouleversé nos vies et la situation actuelle préoccupe de nombreuses personnes. Des défis se posent auxquels nous pourrions difficilement nous préparer : en tant que personnes touchées, en tant que parents, en tant que professionnels de la santé, mais aussi en tant que parents et familles. Voici une offre pour les personnes qui ont besoin d'une conversation en ces temps difficiles.
The Australian and New Zealand Society of Intensive Care Society (ANZICS) has released guidelines for the management of COVID-19 from the intensive care perspective.
The Society of Critical Care Medicine (SCCM) has launched an online training resource for those responding to the COVID-19 pandemic. The number of patients requiring hospital admission is expected to surge which may require the need for non-ICU clinicians to care for critically ill patients.
Critical Care for the non-ICU Clinician provides free online education for healthcare professionals who could benefit from critical care training. This is free training for Non-ICU Clinicians to help them get prepared.
VISIT sccm.org/covid19 TO ACCESS THE TRAINING
2019-Novel Coronavirus (2019-nCoV): estimating the case fatality rate – a word of caution
Preliminary case report on the SARS-CoV-2 cluster in the UK, France, and Spain
Understanding COVID-19 new diagnostic guidelines – a message of reassurance from an internal medicine doctor in Shanghai
Suggestions for thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19
Updates from the EMA
The European Commission and the Head of Medicines Agencies (EMA) support the development and approval of vaccines and treatments for COVID-19 under its recently activated plan for managing emerging health threat.
Consult EMA's special coronavirus disease (COVID-19) website for frequent updates.
Today, we would like to highlight the following EMA updates:
Postponement of the MDR application intended to allow focus on urgent COVID-19 priorities
25 March 2020: Application of the new European Medical Device Directive is planned for the end of May 20. The European Commission has now announced that it is working on a proposal to postpone the date of application by another year. The Commission intends to submit the proposal to the Parliament at the beginning of April. A postponement would relieve pressure from national authorities, notified bodies, manufacturers, and other stakeholders and allow them to concentrate fully on the urgent priorities related to the coronavirus crisis.
Commission working on proposal to postpone MDR application date for one year (pdf)
Call for Expression of Interest for Sponsors and CRO
Until April 19, CEPI is seeking to identify entities that could serve as sponsors or provide clinical research organisation (CRO) support for clinical trials of COVID-19 vaccines.
More details can be found in CEPI's call for Expression of Interest (pdf).
Science magazine overview on the most promising coronavirus treatments being tested in mega trials
27 March 2020: The World Health Organization (WHO) announced a large global trial, called SOLIDARITY, to test four existing treatments on their potential for drug repurposing to treat COVID-19.
Read the full Science magazine article WHO launches global megatrial of the four most promising coronavirus treatments.